Home › Funds › Trilogy Capital Inc. › AVUV

Trilogy Capital Inc. position in AVUV

AVANTIS U S

Trilogy Capital Inc. reported holding 129,343 shares of AVUV (AVANTIS U S) in its Q3 2026 13F filing — a position valued at US$15.2M, representing 0.59% of its reported portfolio and ranking #39 among its reported holdings. Trilogy Capital Inc. has disclosed AVUV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)129.34K sh
Reported value held$15.23M
Portfolio Weight0.59%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Trilogy Capital Inc.'s AVUV position evolved

Trilogy Capital Inc. first disclosed a stake in AVUV in Q3 2023 at 21,211 shares (US$1.7M). The position peaked in Q2 2026 at 125,203 shares, worth US$15.6M. Across 13 filings, Trilogy Capital Inc. increased the stake 12 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 129,343 shares valued at US$15.2M — an increase of 4,140 shares quarter over quarter.. Notable position changes include a 38% increase in Q4 2023 (shares rose 4% over the following quarter), a 83% increase in Q1 2024 (shares fell 4% over the following quarter), a 49% increase in Q2 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 21.21K $1.65M New
Q4 2023 29.33K $2.63M Add
Q1 2024 53.55K $5.02M Add
Q2 2024 66.97K $6.01M Add
Q3 2024 70.77K $6.79M Add
Q4 2024 72.13K $6.96M Add
Q1 2025 77.27K $6.74M Add
Q2 2025 115.50K $10.52M Add
Q3 2025 117.45K $11.69M Add
Q4 2025 118.83K $12.12M Add
Q1 2026 120.15K $13.27M Add
Q2 2026 125.20K $15.62M Add
Q3 2026 129.34K $15.23M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVUV and 13F data

AVUV (AVANTIS U S) is a company whose sector is not yet classified in our data. 39 other funds we track also report a position in AVUV — the largest reported positions include Creative Planning (US$2.69B), Focus Partners Wealth (US$757.9M), Focus Partners Advisor Solutions, LLC (US$422.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVUV

All AVUV fund holders →

FAQ

How long has Trilogy Capital Inc. held AVUV?

Trilogy Capital Inc. has disclosed AVUV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Trilogy Capital Inc.'s current position in AVUV?

As of Q3 2026, Trilogy Capital Inc. holds 129.34K shares of AVUV (AVANTIS U S), valued at $15.23M, representing 0.59% of its reported portfolio and ranking #39.

Has Trilogy Capital Inc. been buying or selling AVUV?

In the latest 13F filing (Q3 2026), Trilogy Capital Inc. increased its position in AVUV. The position peaked in Q2 2026 at 125.20K shares.

Which other funds hold AVUV?

Other major institutional holders of AVUV include Creative Planning, Focus Partners Wealth, Focus Partners Advisor Solutions, LLC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.